Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAZIAR ESLAMI FARSANI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1831585140
CMS profile
2790061
Location
RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$2,022.83

111 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,022.83 111

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 3; records 1–50 of 111 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAZIAR ESLAMI FARSANI

NPI 1831585140 · CMS profile ID 2790061

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

RIVERSIDE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 3; records 1–50 of 111 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831585140?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAZIAR ESLAMI FARSANI, NPI 1831585140, CMS profile ID 2790061. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 111 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831585140?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MAZIAR ESLAMI FARSANI, NPI 1831585140, CMS profile ID 2790061. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 3; records 1–50 of 111 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831585140?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MAZIAR ESLAMI FARSANI, NPI 1831585140, CMS profile ID 2790061, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 3; records 1–50 of 111 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1831585140?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

111 matching records · $2,022.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 111 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 111.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $31.3112/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954902449 CMS
Genentech USA, Inc. $24.1012/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950717513 CMS
ABBVIE INC. $0.1612/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928905 CMS
ABBVIE INC. $1.5512/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928907 CMS
Novartis Pharmaceuticals Corporation $15.3812/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621429 CMS
Biohaven Pharmaceutical Holding Company Ltd. $12.1812/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923584611 CMS
Lilly USA, LLC $25.2712/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918183595 CMS
Novartis Pharmaceuticals Corporation $7.1412/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621421 CMS
ABBVIE INC. $15.3912/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928903 CMS
Novartis Pharmaceuticals Corporation $11.2011/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621427 CMS
Novartis Pharmaceuticals Corporation $0.7211/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621423 CMS
Novartis Pharmaceuticals Corporation $11.2611/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621425 CMS
ABBVIE INC. $3.5111/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928901 CMS
Biogen, Inc. $25.1211/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923425345 CMS
Biogen, Inc. $26.1211/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923434691 CMS
Novartis Pharmaceuticals Corporation $17.0811/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621419 CMS
Alnylam Pharmaceuticals Inc. $25.6211/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 926079033 CMS
Novartis Pharmaceuticals Corporation $14.7211/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621413 CMS
UCB, Inc. $32.4411/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965219631 CMS
Avanir Pharmaceuticals, Inc. $9.6411/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 935999201 CMS
Novartis Pharmaceuticals Corporation $17.0110/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621417 CMS
ABBVIE INC. $2.2810/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928895 CMS
ABBVIE INC. $6.6710/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928897 CMS
ABBVIE INC. $7.6810/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928899 CMS
Novartis Pharmaceuticals Corporation $19.1610/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621415 CMS
EISAI INC. $23.0410/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908063957 CMS
Lundbeck LLC $28.7410/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945745811 CMS
ABBVIE INC. $5.8210/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890928893 CMS
Novartis Pharmaceuticals Corporation $102.1510/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621353 CMS
Amgen Inc. $17.5310/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939425887 CMS
Novartis Pharmaceuticals Corporation $14.4110/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621411 CMS
Biogen, Inc. $27.5410/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923397259 CMS
Biogen, Inc. $92.5110/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923465481 CMS
Teva Pharmaceuticals USA, Inc. $17.4910/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954902282 CMS
Novartis Pharmaceuticals Corporation $7.8010/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621409 CMS
Amneal Pharmaceuticals LLC $28.1209/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956578429 CMS
ARGENX US, INC. $26.4809/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951637473 CMS
Avanir Pharmaceuticals, Inc. $16.5409/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 935988251 CMS
Novartis Pharmaceuticals Corporation $9.2409/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621407 CMS
Allergan, Inc. $23.1609/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 889879089 CMS
Novartis Pharmaceuticals Corporation $14.7709/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621405 CMS
Biogen, Inc. $22.8309/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923453451 CMS
Novartis Pharmaceuticals Corporation $8.3109/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621403 CMS
Novartis Pharmaceuticals Corporation $15.7209/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621395 CMS
Biogen, Inc. $25.4209/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923392007 CMS
Alexion Pharmaceuticals, Inc. $23.4608/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915508377 CMS
Celgene Corporation $14.7508/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932731423 CMS
Novartis Pharmaceuticals Corporation $14.1708/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621401 CMS
Novartis Pharmaceuticals Corporation $5.8708/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621399 CMS
Novartis Pharmaceuticals Corporation $21.2308/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893621397 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $121.72 1
PY2021 $413.39 7
PY2022 $2,022.83 111
PY2023 $3,286.57 154
PY2024 $1,963.43 80
PY2025 $3,339.04 113

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $8,360.88 1
PY2023 Principal investigator $106,529.02 2
PY2022 Principal investigator $265,685.70 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $965.42 09/26/2023 Non-covered Recipient Entity
THE NEUROLOGY GROUP
A Single-arm, Prospective, Multi-center Study to Explore Maintained Efficacy With Ofatumumab Therapy in Patients With Relapsing Multiple Sclerosis Who Discontinue Intravenously Delivered Anti-CD20 Monoclonal Antibody (aCD20 mAb) Therapy (OLIKOS) No dispute reported 06/30/2026 1017204463
Principal investigator 1 Novartis Pharmaceuticals Corporation $105,563.60 01/01/2023 Non-covered Recipient Entity
THE NEUROLOGY GROUP
A Single-arm, Prospective, Multi-center Study to Explore Maintained Efficacy With Ofatumumab Therapy in Patients With Relapsing Multiple Sclerosis Who Discontinue Intravenously Delivered Anti-CD20 Monoclonal Antibody (aCD20 mAb) Therapy (OLIKOS) No dispute reported 06/30/2026 1017204071